483
Michael T. Lin, M.D.Michael T. Lin, M.D. – FDA 483, Jul 15, 2022
Record Details
An FDA inspection of Michael T. Lin, M.D., a clinical investigator in New York, NY, revealed a significant violation related to human subject protection. The firm failed to obtain informed consent from a human subject prior to administering a study drug and conducting related tests, as required by protocol and federal regulations. This indicates a serious lapse in ethical and regulatory compliance for clinical trials.
View Company Profile
ID · cf90a592-55c4-4905-8cfb-d91d453cb135
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.